Laura Shawver - Net Worth and Insider Trading

Laura Shawver Net Worth

The estimated net worth of Laura Shawver is at least $3 Million dollars as of 2024-11-05. Laura Shawver is the Director of ARS Pharmaceuticals Inc and owns about 210,346 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $3 Million. Details can be seen in Laura Shawver's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laura Shawver has not made any transactions after 2023-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Laura Shawver

To

Laura Shawver Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Laura Shawver owns 5 companies in total, including Relay Therapeutics Inc (RLAY) , Nkarta Inc (NKTX) , and Synthorx Inc (THOR) among others .

Click here to see the complete history of Laura Shawver’s form 4 insider trades.

Insider Ownership Summary of Laura Shawver

Ticker Comapny Transaction Date Type of Owner
RLAY Relay Therapeutics Inc 2020-07-15 director
NKTX Nkarta Inc 2020-07-09 director
THOR Synthorx Inc 2020-01-23 director & President and CEO
LIMIT LIMIT 2020-12-03 director & Chief Executive Officer
LIMIT LIMIT 2023-09-01 director & Chief Executive Officer

Laura Shawver Latest Holdings Summary

Laura Shawver currently owns a total of 1 stock. Laura Shawver owns 210,346 shares of ARS Pharmaceuticals Inc (SPRY) as of September 1, 2023, with a value of $3 Million.

Latest Holdings of Laura Shawver

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SPRY ARS Pharmaceuticals Inc 2023-09-01 210,346 15.07 3,169,914

Holding Weightings of Laura Shawver


Laura Shawver Form 4 Trading Tracker

According to the SEC Form 4 filings, Laura Shawver has made a total of 7 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 100,000 shares on September 1, 2023, which brought Laura Shawver around $771,000.

Insider Trading History of Laura Shawver

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Laura Shawver Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Laura Shawver Ownership Network

Ownership Network List of Laura Shawver

No Data

Ownership Network Relation of Laura Shawver

Insider Network Chart

Laura Shawver Owned Company Details

What does Relay Therapeutics Inc do?

Who are the key executives at Relay Therapeutics Inc?

Laura Shawver is the director of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include Vice President & Finance Thomas Catinazzo , See remarks Peter Rahmer , and See Remarks Donald A Bergstrom .

Relay Therapeutics Inc (RLAY) Insider Trades Summary

Over the past 18 months, Laura Shawver made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 132,111 shares made by Peter Rahmer , a net sale of 44,032 shares made by Thomas Catinazzo , and a net sale of 18,539 shares made by Donald A Bergstrom .

In summary, during the past 3 months, insiders sold 22,688 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 22,688 shares. During the past 18 months, 291,361 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 291,361 shares.

Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Relay Therapeutics Inc Insider Transactions

No Available Data

Laura Shawver Mailing Address

Above is the net worth, insider trading, and ownership report for Laura Shawver. You might contact Laura Shawver via mailing address: 1255 Crescent Green Drive, Suite 250, Cary Nc 27518.